Order Article Reprints

Winarto H, Habiburrahman M, Anggraeni TD, Nuryanto KH, Julianti RA, Purwoto G, Andrijono A. The Utility of Pre-Treatment Inflammation Markers as Associative Factors to the Adverse Outcomes of Vulvar Cancer: A Study on Staging, Nodal Involvement, and Metastasis Models. Journal of Clinical Medicine. 2023; 12(1):96. https://doi.org/10.3390/jcm12010096

Winarto, Hariyono, Muhammad Habiburrahman, Tricia Dewi Anggraeni, Kartiwa Hadi Nuryanto, Renny Anggia Julianti, Gatot Purwoto, and Andrijono Andrijono. 2023. "The Utility of Pre-Treatment Inflammation Markers as Associative Factors to the Adverse Outcomes of Vulvar Cancer: A Study on Staging, Nodal Involvement, and Metastasis Models" Journal of Clinical Medicine 12, no. 1: 96. https://doi.org/10.3390/jcm12010096

Winarto, H., Habiburrahman, M., Anggraeni, T. D., Nuryanto, K. H., Julianti, R. A., Purwoto, G., & Andrijono, A. (2023). The Utility of Pre-Treatment Inflammation Markers as Associative Factors to the Adverse Outcomes of Vulvar Cancer: A Study on Staging, Nodal Involvement, and Metastasis Models. Journal of Clinical Medicine, 12(1), 96. https://doi.org/10.3390/jcm12010096